李美玉, 李晓飞, 张天爱, 郭莲怡. IPO5基因表达对食管癌恶性进展的促进作用[J]. 中国肿瘤临床. DOI: 10.12354/j.issn.1000-8179.2022.20220590
引用本文: 李美玉, 李晓飞, 张天爱, 郭莲怡. IPO5基因表达对食管癌恶性进展的促进作用[J]. 中国肿瘤临床. DOI: 10.12354/j.issn.1000-8179.2022.20220590
shu
Meiyu Li, Xiaofei Li, Tianai Zhang, Lianyi Guo. Importin5 gene expression promotes malignant progression of esophageal cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY. DOI: 10.12354/j.issn.1000-8179.2022.20220590
Citation: Meiyu Li, Xiaofei Li, Tianai Zhang, Lianyi Guo. Importin5 gene expression promotes malignant progression of esophageal cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY. DOI: 10.12354/j.issn.1000-8179.2022.20220590
shu

IPO5基因表达对食管癌恶性进展的促进作用

Importin5 gene expression promotes malignant progression of esophageal cancer

    摘要
  • 摘要:
      目的  探讨importin5（IPO5）基因的表达对食管癌（esophageal cancer, EC）进展的影响以及相关作用机制。
      方法  收集2020年9 月至2022 年4 月50 例于锦州医科大学附属第一医院确诊为EC的患者的资料及手术标本，免疫组化验证IPO5在癌组织与癌旁组织中的表达情况，评估IPO5与患者临床信息的相关性；通过慢病毒转染构建IPO5基因沉默EC细胞模型；通过 CCK-8实验、Transwell侵袭实验、细胞划痕实验检测细胞增殖、侵袭及迁移能力；应用流式细胞术检测细胞周期，Western blot实验检测细胞周期相关蛋白的表达及RAS通路相关蛋白的表达。构建裸鼠皮下成瘤模型，免疫组化验证Ki-67表达。
      结果  临床实验中，IPO5在癌组织的表达明显高于癌旁组织（P<0.01），并与肿瘤大小、分期及分化程度呈正相关（P<0.05）。IPO5在EC细胞中的表达高于正常食管细胞，尤其是ECA109及OE33细胞（P<0.01）。与阴性对照组相比，IPO5干扰组细胞增殖能力减弱（P<0.05）、侵袭能力减弱（P<0.01）。IPO5基因沉默后EC细胞生长周期阻滞于G2期，细胞周期相关蛋白表达减少。sh-IPO5干扰后RAS-ERK通路下游蛋白表达水平下降（P<0.05）。裸鼠成瘤实验证实敲除IPO5后肿瘤缩小（P<0.05），Ki-67表达减少（P<0.01）。
      结论  IPO5在EC组织中高表达，抑制IPO5的表达对于EC细胞的生长和迁移存在显著影响，IPO5通过激活RAS-ERK信号通路促进EC的进展。

     

    Abstract:
      Objective  To investigate the effect and mechanism of importin5 (IPO5) gene expression on esophageal cancer (EC) progression.
      Methods  The data and surgical specimens of 50 patients diagnosed with EC in The First Affiliated Hospital of Jinzhou Medical University from September 2020 to April 2022 were collected. The expression of IPO5 in cancer tissues and adjacent tissues was determined using immunohistochemistry. The correlation between IPO5 expression and patient clinical information was evaluated. Lentivirus transfection was used to generate an IPO5-silenced EC cell model. Cell proliferation, invasion, and migration were measured using CCK-8, Transwell invasion, and cell scratch assays. Flow cytometry and Western blot were used to detect cell cycle-related and RAS pathway-related proteins. A subcutaneous tumorigenesis nude mouse model was established, and Ki-67 expression was determined using immunohistochemistry.
      Results  In clinical samples, IPO5 expression was significantly higher in cancer tissues than that in adjacent tissues (P<0.01) and was positively correlated with tumor size, stage, and degree of differentiation (P<0.05). EC cells expressed higher IPO5 levels than normal esophageal cells, especially ECA109 and OE33 cells (P<0.01). The proliferation and invasion abilities of the IPO5 gene silencing group were decreased (P<0.05 and P<0.01, respectively) compared with that of the negative control group. After IPO5 silencing, the EC cells were arrested in the G2 phase of the cell cycle, and the expression of cell cycle-related proteins decreased. The level of activated RAS-ERK pathway proteins decreased after sh-IPO5 knockdown (P<0.05). Tumorigenesis experiments in nude mice confirmed that tumor shrank ( P <0.05) and Ki-67 expression decreased (P<0.01) after IPO5 gene silending.
      Conclusions  IPO5 is highly expressed in EC tissues, and inhibition of IPO5 has a significant inhibitory effect on the growth and migration of EC cells. IPO5 activates the RAS-ERK signaling pathway and promotes EC development.

     

    • HTML全文
    • 参考文献(29)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回